Article Text

Download PDFPDF
A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients
  1. V. E. Von Gruenigen1,2,
  2. L. J. White3,
  3. M. S. Kirven2,
  4. A. L. Showalter4,
  5. M. P. Hopkins1,2 and
  6. E. L. Jenison1,2
  1. 1Division of Gynecologic Oncology and
  2. 2Department of Obstetrics and Gynecology
  3. 3Northeastern Ohio Universities College of Medicine, Akron General Medical Center, Akron, Ohio;
  4. 4Twin Springs Medical Center, Kidron, Ohio
  1. Address correspondence and reprint requests to: Dr. Vivian E. von Gruenigen, Assistant Professor, Northeastern Ohio Universities College of Medicine, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Akron General Medical Center, 224 W. Exchange Street, Suite 140, Akron, OH 44302. E-mail: vvongr{at}aol.com.

Abstract

Our objective was to describe and compare the use of complementary and alternative medicine (CAM) in gynecology and gynecological oncology patients. Five hundred and twenty-nine gynecology and gynecological oncology patients completed a questionnaire regarding CAM use. Overall, 56.3% of gynecology and gynecological oncology patients reported current use of CAM. Therapies used included nutritional supplements (20%), prayer as medical therapy (17%), exercise as medical therapy (12%), megavitamins (10%), and green tea (10%). While 69.5% believed CAM to be beneficial, only 31.6% discussed these therapies with their physician. The women spent a mean of $656.22 on CAM (range $0–$7,000), with 31.7% receiving some insurance reimbursement. Gynecologic oncology patients (n =161) used CAM significantly more than gynecology patients (n =368) (66% vs. 52%, 95% CI=0.046–0.230, P =0.004). Gynecological oncology patients also spent more for CAM, with a mean expenditure of $711 versus $622 by gynecology patients. Within the gynecological oncology patient group, there were 69 patients currently receiving modern medical treatments for cancer; among these patients, 58% reported using CAM; of these, 39.3% communicated their use of CAM to their physician. Patients in this group spent an average of $1,178 on CAM during their illness, with only 6.3% receiving insurance reimbursement. Benefits from CAM were perceived by 54.5% in this group. We concluded that cancer patients have a higher usage rate and expenditure for CAM, particularly while they are receiving medical therapy, and are more likely to discuss the use of alternative therapies with their physicians. CAM was perceived as helpful by patients despite the lack of scientific data about its effect.

  • complementary and alternative medicines
  • gynecological oncology
  • gynecology

Statistics from Altmetric.com

Footnotes

  • Presented at the annual meeting of the Society of Gynecologic Oncologists, San Diego, CA, February, 2000.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.